We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Two Simple Methods Prepare DNA Suitable For Digital PCR

By LabMedica International staff writers
Posted on 19 Aug 2020
Print article
Cells in wells of a 96 well-plate before (A) and after (B) lysis cell by Direct PCR (B1) and Chelex100 (B2) (Photo courtesy of University Hospital Hamburg‐Eppendorf).
Cells in wells of a 96 well-plate before (A) and after (B) lysis cell by Direct PCR (B1) and Chelex100 (B2) (Photo courtesy of University Hospital Hamburg‐Eppendorf).
Although DNA of high quality can be easily prepared from cultured cells with commercially available kits, many studies involve a large number of samples which increases the cost drastically.

In addition, a limited amount of each sample is often a challenge, for example, for studies using cells of primary cultures for testing multiple drugs at multiple concentrations in multiple replicates, and studies or diagnosis involving defined subpopulations of human immune cells.

Medical scientists at the University Hospital Hamburg‐Eppendorf (Hamburg, Germany) used cells from a primary culture derived from a benign plexiform neurofibroma, a melanoma cell line, and a human fibroblast line. The cells were seeded into wells of 96‐well plates with at different concentrations, each in three replicates. The plates were incubated overnight for the cells to attach the cultural surface and subjected to DNA extraction on the next day after checking the adhesive living cells under a microscope.
After removing the medium, the wells were washed twice with PBS. Subsequently, 70 μL of the Direct PCR lysis reagent (PeqLab, Erlangen, Germany) supplemented with 0.2 mg/mL fresh proteinase K together with 70μL water was added to each well containing adhesive living cells. Supernatants containing the extracted DNA were further purified by precipitation. The team also lysed cells using chelex100 powder (Bio-Rad, Hercules, CA, USA). Conventional polymerase chain reaction (PCR) was carried out using 2 µL out of the 10 µL DNA and a primer pair for an exon of the NF1 gene which is used for the routine genetic diagnosis in their laboratory.

The investigators reported that for 1,000 cells from one primary culture and two tumor cell lines, DNA was reproducible and obtained with recovery rate (obtained/expected amount of DNA) in the range of 50%‐90% as measured by the fluorometer dyes instrument Qubit (Thermo Fisher Scientific, Waltham, MA, USA). For digital PCR, more than 1,600 positive droplets were obtained for DNA from 1,000 cells using the Direct PCR method, corresponding to a yield efficiency of approximately 80%. Further reducing the number of cells down to 100 would be possible with 160 positive droplets expected. Both reagents are inexpensive at EUR 0.08/sample.

The authors concluded that the two methods were efficient; especially the Direct PCR reagent‐based method provides a simple and inexpensive method for preparing DNA suitable for digital PCR from small number of cells. The study was published on August 5, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:

University Hospital Hamburg‐Eppendorf
PeqLab
Bio-Rad
Thermo Fisher Scientific
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more